Clearstead Advisors, LLC Cooper Companies, Inc. Transaction History

Clearstead Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$306.88 - $380.0 $4,296 - $5,320	14 Added 12.5%	126 $47,000
Q3 2023 Nov 07, 2023	BUY	$315.92 - $397.36 $3,159 - $3,973	10 Added 9.8%	112 $35,000
Q2 2023 Aug 07, 2023	SELL	$346.15 - $392.09 $2,423 - $2,744	-7 Reduced 6.42%	102 $39,000
Q1 2023 May 09, 2023	SELL	$323.56 - $373.36 $323 - $373	-1 Reduced 0.91%	109 $40,000
Q4 2022 Feb 14, 2023	BUY	$248.67 - $334.17 $497 - $668	2 Added 1.85%	110 $36,000
Q3 2022 Nov 14, 2022	BUY	$263.81 - $337.27 $1,319 - $1,686	5 Added 4.85%	108 $29,000
Q2 2022 Aug 12, 2022	BUY	$301.4 - $428.42 $5,425 - $7,711	18 Added 21.18%	103 $32,000
Q3 2021 Nov 12, 2021	SELL	$396.76 - $455.92 $3,174 - $3,647	-8 Reduced 8.6%	85 $35,000
Q2 2021 Aug 12, 2021	BUY	$372.36 - $412.07 $2,978 - $3,296	8 Added 9.41%	93 $37,000
Q4 2020 Feb 11, 2021	SELL	$319.05 - $363.32 $4,785 - $5,449	-15 Reduced 15.0%	85 $31,000
Q1 2020 May 14, 2020	BUY	$243.44 - $359.98 $24,344 - $35,998	100 New	100 $28,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearstead Advisors, LLC with notifications on news.